aCT1 bound to BTF3 in our proteomic analysis and consistent with this, the gene that encodes N-cadherin, CDH2, was significantly reduced in aCT1-treated samples in our gene expression analysis using the NanoString nCounter Breast Cancer 360 panel. This evidence concerns the gene CDH2 and breast carcinoma.